Description
A cannabidiol (CBD) analog that acts as a selective antagonist of abnormal CBD (Abn-CBD) at the non-CB1/CB2 endothelial receptor; does not bind to CB1 or CB2 receptors at concentrations up to 30 µM and inhibits the vasorelaxant effects of Abn-CBD in vitro and in whole animals; blocks the Abn-CBD-induced activation of the PtdIns 3-kinase/Akt pathway in human umbilical vein endothelial cells
Formal name: 1,3-dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-benzene
Synonyms:
Molecular weight: 286.4
CAS: 536697-79-7
Purity: ≥95%
Formulation: A solution in methyl acetate
Product Type|Biochemicals|Receptor Pharmacology||Research Area|Cardiovascular System|Vasculature|Vasoconstriction||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors